PALE
MCID: PST092
MIFTS: 29

Posttransplant Acute Limbic Encephalitis (PALE)

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Posttransplant Acute Limbic Encephalitis

MalaCards integrated aliases for Posttransplant Acute Limbic Encephalitis:

Name: Posttransplant Acute Limbic Encephalitis 58
Pale 58

Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

Orphanet 58 ORPHA163921

Summaries for Posttransplant Acute Limbic Encephalitis

MalaCards based summary : Posttransplant Acute Limbic Encephalitis, also known as pale, is related to clear cell acanthoma and deficiency anemia. The drugs mometasone furoate and Lansoprazole have been mentioned in the context of this disorder. Affiliated tissues include skin, liver and breast.

Related Diseases for Posttransplant Acute Limbic Encephalitis

Diseases related to Posttransplant Acute Limbic Encephalitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 236)
# Related Disease Score Top Affiliating Genes
1 clear cell acanthoma 11.9
2 deficiency anemia 11.3
3 obesity, early-onset, with adrenal insufficiency and red hair 11.2
4 pernicious anemia 11.2
5 oculocutaneous albinism 11.2
6 biliary atresia 11.2
7 hepatitis b 11.2
8 syncope 11.2
9 iron-refractory iron deficiency anemia 11.2
10 anemia, sideroblastic, 1 11.2
11 cardiomyopathy, infantile histiocytoid 11.1
12 glucosephosphate dehydrogenase deficiency 11.1
13 thoracic outlet syndrome 11.1
14 tietz albinism-deafness syndrome 11.0
15 clouston syndrome 11.0
16 optic atrophy 1 11.0
17 pyruvate kinase deficiency of red cells 11.0
18 cyclic vomiting syndrome 11.0
19 alpha-thalassemia 11.0
20 capillary malformation-arteriovenous malformation 1 11.0
21 erythroderma, ichthyosiform, congenital reticular 11.0
22 majeed syndrome 11.0
23 beta-thalassemia 11.0
24 macular dystrophy with central cone involvement 11.0
25 paroxysmal nocturnal hemoglobinuria 11.0
26 thalassemia 11.0
27 lepromatous leprosy 11.0
28 congenital dyserythropoietic anemia 11.0
29 waardenburg's syndrome 11.0
30 hypochromic microcytic anemia with iron overload 11.0
31 methylmalonic acidemia with homocystinuria 11.0
32 alagille syndrome 1 10.9
33 hashimoto thyroiditis 10.9
34 klippel-trenaunay-weber syndrome 10.9
35 systemic lupus erythematosus 10.9
36 chromosome 5q deletion syndrome 10.9
37 motion sickness 10.9
38 noonan syndrome 1 10.9
39 optic atrophy 3, autosomal dominant 10.9
40 paget disease, extramammary 10.9
41 pheochromocytoma 10.9
42 sturge-weber syndrome 10.9
43 atransferrinemia 10.9
44 folate malabsorption, hereditary 10.9
45 glutamate formiminotransferase deficiency 10.9
46 ghosal hematodiaphyseal dysplasia 10.9
47 hemolytic uremic syndrome, atypical 1 10.9
48 thiamine-responsive megaloblastic anemia syndrome 10.9
49 myeloma, multiple 10.9
50 3-methylglutaconic aciduria, type iii 10.9

Graphical network of the top 20 diseases related to Posttransplant Acute Limbic Encephalitis:



Diseases related to Posttransplant Acute Limbic Encephalitis

Symptoms & Phenotypes for Posttransplant Acute Limbic Encephalitis

Drugs & Therapeutics for Posttransplant Acute Limbic Encephalitis

Drugs for Posttransplant Acute Limbic Encephalitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 204)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7
2
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
3
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
4
Methamphetamine Approved, Illicit Phase 4 537-46-2 10836
5
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
6
Lactulose Approved Phase 4 4618-18-2 11333
7
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
8
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
9
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
10
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
11
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
12
Polyestradiol phosphate Approved Phase 4 28014-46-2
13
Pantoprazole Approved Phase 4 102625-70-7 4679
14
Calcium carbonate Approved, Investigational Phase 4 471-34-1
15
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
16
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
17
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
19
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
20 Opiate Alkaloids Phase 4
21 Liver Extracts Phase 4
22 Antidepressive Agents Phase 4
23 Anti-Inflammatory Agents Phase 4
24 Hormones Phase 4
25 Central Nervous System Stimulants Phase 4
26 Adrenergic Agents Phase 4
27 Sympathomimetics Phase 4
28 Neurotransmitter Agents Phase 4
29 Dopamine Agents Phase 4
30 Hormone Antagonists Phase 4
31 Antiemetics Phase 4
32 Immunologic Factors Phase 4
33 Immunosuppressive Agents Phase 4
34 Antineoplastic Agents, Hormonal Phase 4
35 Cathartics Phase 4
36 Anti-HIV Agents Phase 4
37 Reverse Transcriptase Inhibitors Phase 4
38 Laxatives Phase 4
39 Anti-Retroviral Agents Phase 4
40 Vaccines Phase 4
41 Estradiol 17 beta-cypionate Phase 4
42 Contraceptives, Oral, Combined Phase 4
43 Contraceptive Agents Phase 4
44 Contraceptives, Oral Phase 4
45 Estradiol 3-benzoate Phase 4
46 Norgestimate, ethinyl estradiol drug combination Phase 4
47 Calcium, Dietary Phase 4
48 Dextrans Phase 4
49 glucocorticoids Phase 4
50 Ophthalmic Solutions Phase 4

Interventional clinical trials:

(show top 50) (show all 97)
# Name Status NCT ID Phase Drugs
1 Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial Unknown status NCT00615875 Phase 4 naproxen;placebo
2 a Randomized, Double Blind, Placebo-controlled, Multicenter Clinical Trial of Efficacy and Safety of Shu Gan yi Yang Capsule in the Treatment of Depression Associated With Erectile Dysfunction (Stagnation of Liver qi and Kidney Deficiency) Unknown status NCT03290313 Phase 4 shu gan yi yang capsule;shu gan yi yang capsule simulation agent
3 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate. A Randomized Controlled Trial Unknown status NCT02278081 Phase 4 lansoprazole;placebo
4 A Phase IV Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral Digital Subtraction Angiography (DSA) Completed NCT00740207 Phase 4 VISIPAQUE 270;Isovue 250
5 Clinical Outcomes of Endoscopic Resection for Treating Extremely Well Differentiated Intestinal-type Adenocarcinoma (WHYX Lesion) Completed NCT01451034 Phase 4
6 Blood Glucose Response After Oral Intake of Lactulose (Laevolac®) in Mildly Constipated Patients With Diabetes Mellitus Type 2 Completed NCT03666546 Phase 4 Lactulose crystals 20 g;Lactulose crystals 30 g;Lactulose liquid 20 g;Lactulose liquid 30 g;Glucose;Still water
7 An Open-label Single-Center, 4-Period William's Cross-Over Design Drug Interaction Trial to Determine the Effects of Sorbitol-Containing Solutions on Lamivudine Exposure Following Administration of Lamivudine Oral Solution in Healthy Adult Subjects Completed NCT02634073 Phase 4 Lamivudine;Sorbitol
8 Ivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan Completed NCT02241044 Phase 4
9 Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules With RotaTeq® and Rotarix® Completed NCT01266850 Phase 4
10 An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali Completed NCT02286895 Phase 4
11 A Two Different Chemoprophylaxis Approaches After Phacoemulsification Surgery in One Thousand Patients in Iraq :a Clinical Trial Completed NCT03634852 Phase 4 Moxifloxacin hydrochloride 0.5% eye drops;Dexamethasone 0.1% eye drops;Intracameral Moxifloxacin 0.1%;Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml
12 A Randomized Comparison of Ultrasound Guided Supraclavicular Block(UGSB) and General Anesthesia (GA) to IV Narcotics and General Anesthesia for Postoperative Pain Relief in Children With Supracondylar Fractures. Active, not recruiting NCT02056288 Phase 4 Fentanyl;Ropivacaine
13 RECARE (REnal Safety Following the Intra-Arterial Administration of Iopamidol vs. Iodixanol During Coronary AngiogRaphy in DiabEtic Patients) Terminated NCT00782639 Phase 4 Iopamidol injection 76%;iodixanol
14 Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients:A Multicentre Randomized Double-Blind Trail of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Terminated NCT01402219 Phase 4 Iopamidol injection 76%;iodixanol
15 Irinotecan-Eluting Bead (DEBIRI) for Unresectable Liver Metastases From Colorectal Cancer After Systemic Chemotherapy Failure Unknown status NCT03175016 Phase 2, Phase 3 Irinotecan
16 Open Label, Phase III Safety, Efficacy, and Pharmacokinetic Study of NABI-IGIV 10% [Immune Globulin Intravenous (Human), 10%] in Subjects With Primary Immune Deficiency Disorders (PIDD) Completed NCT00538915 Phase 3
17 An Open Label, Randomised, Three Arm, Single Dose, Multicentre, Parallel Group Study in Healthy Subjects to Compare the Pharmacokinetics of Subcutaneous Mepolizumab When Delivered as a Liquid Drug Product in a Safety Syringe or an Auto Injector With a Reconstituted Lyophilised Drug Product From a Vial Completed NCT03014674 Phase 3
18 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of an Autoinjector for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 204959) Completed NCT03099096 Phase 3 Mepolizumab
19 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667) Completed NCT03021304 Phase 3 Mepolizumab
20 A Randomised, Double-blind, Parallel Group PhIII Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab as an Add on to Maintenance Treatment in Adults With Severe Bilateral Nasal Polyps - SYNAPSE (StudY in NAsal Polyps Patients to Assess the Safety and Efficacy of Mepolizumab) Completed NCT03085797 Phase 3 Mepolizumab;Placebo;Mometasone furoate
21 A 52-week, Phase III, Open-label, Multi-center Study to Evaluate Efficacy and Safety of GSK1278863 in Japanese Non-dialysis and Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease Completed NCT02791763 Phase 3 1 to 4 mg tablets of GSK1278863;6 mg GSK1278863 tablet;Epoetin beta pegol
22 A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib Recruiting NCT03459534 Phase 3 Radotinib HCl
23 Impact of Combination Therapy Between Hydroxy Urea, Omega 3, Nigella Sativa and Honey on Antioxidant-oxidant Status and Reduction of Iron Overload in Pediatric Major Thalassemia Recruiting NCT04292314 Phase 2, Phase 3 Omega 3;Nigella Sativa Oil;Hydroxyurea;Honey;Deferoxamine
24 A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease Active, not recruiting NCT02697734 Phase 3 osilodrostat;osilodrostat Placebo
25 A Phase II, Randomized, Two-Part, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Safety, Tolerability, and Efficacy of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections Completed NCT02045797 Phase 2 GSK2140944 Lyophile;GSK2140944 Capsules
26 A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose Study to Evaluate the Efficacy and Safety of Intravenous GSK679586 in Patients With Severe Asthma Completed NCT00843193 Phase 2 INTRAVENOUS GSK679586;INTRAVENOUS PLACEBO;FLUTICASONE PROPIONATE
27 A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae Completed NCT02294682 Phase 2 GSK2140944
28 Investigations of Naproxen Treatment Effects in Pre-clinical Alzheimer's Disease (INTREPAD) Completed NCT02702817 Phase 2 Naproxen;Placebo
29 Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer Completed NCT02015754 Phase 2 DEBIRI
30 The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis Completed NCT02448082 Phase 2
31 A Pilot Phase 1/2, Double Blind, Parallel Group, Controlled Study of the Safety, Tolerability and Preliminary Efficacy Evaluation of Intravitreally Administered Pfenex Ranibizumab Biosimilar Versus Lucentis for the Treatment of Neovascular AMD Completed NCT02121353 Phase 1, Phase 2 Lucentis;PF582
32 An Open-Label, Phase II, Study to Evaluate Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer Receiving Treatment With Trastuzumab in Combination With Lapatinib or Chemotherapy (EGF117165) Completed NCT02213042 Phase 2 Lapatinib
33 A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B Completed NCT01838655 Phase 1, Phase 2 Nitisinone
34 Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers Completed NCT00066066 Phase 2 Metronidazole;Amoxicillin;Doxycycline
35 COMbination of Bipolar Androgen Therapy and Nivolumab in Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting NCT03554317 Phase 2 Testosterone cypionate;Nivolumab
36 High Dose Testosterone in Men With Advanced Prostate Cancer and Homologous Recombination Deficiency Recruiting NCT03522064 Phase 2 Testosterone Enanthate
37 Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 Recruiting NCT04354259 Phase 2 Peginterferon Lambda-1A
38 A Phase II Study to Determine Sequential Response to Bipolar Androgen Therapy (BAT) Followed by Enzalutamide or Abiraterone Post-BAT in Men With Prostate Cancer Progressing on Combined Androgen Ablative Therapies Recruiting NCT02090114 Phase 2 Testosterone cypionate;Testosterone Enanthate;Abiraterone acetate (Cohort B = CLOSED TO ACCRUAL);Enzalutamide (Cohort A = CLOSED TO ACCRUAL)
39 A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602). Active, not recruiting NCT03177239 Phase 2 Nivolumab;Ipilimumab
40 Examining an Intervention to Reduce Underage DUI and Riding With Impaired Drivers Active, not recruiting NCT03506880 Phase 2
41 A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer Active, not recruiting NCT02286921 Phase 2 Testosterone cypionate;Enzalutamide;Testosterone Enanthate
42 Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis: A Randomized Control Trial Enrolling by invitation NCT04130451 Phase 1, Phase 2 PYODINE AND TALC SLURRY
43 A Randomized Phase II Study Comparing Sequential High Dose Testosterone and Enzalutamide to Enzalutamide Alone in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer Not yet recruiting NCT04363164 Phase 2 Testosterone cypionate;Enzalutamide;Testosterone enanthate
44 Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients Terminated NCT01808261 Phase 2 GSK249320 100/mg;Placebo
45 A Single-centre, Open Single-arm Study Where the Safety, Tolerability and Efficacy of Subcutaneously Administered ILB Will be Evaluated in Patients With Amyotrophic Lateral Sclerosis Terminated NCT03613571 Phase 2 ILB
46 A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients Undergoing Oesophagectomy Surgery Terminated NCT02221037 Phase 2 GSK2862277;Placebo
47 A Phase II Study of Irinotecan HCI in Patients With Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas Terminated NCT00360828 Phase 2 Irinotecan Hydrochloride (HCI) Treatment;Continued Irinotecan Hydrochloride (HCI) Treatment
48 A Two Part Phase IIa Study, to Evaluate the Safety and Tolerability, Pharmacokinetics, Proof of Mechanism and Potential for Efficacy of an Anti-IL-7 Receptor-α Monoclonal Antibody (GSK2618960) in the Treatment of Primary Sjögren's Syndrome Withdrawn NCT03239600 Phase 2 GSK2618960 2 mg/kg;Placebo;Methotrexate
49 A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects Completed NCT00460707 Phase 1 Casopitant 150 mg;Ketoconazole;Casopitant 150 mg matching placebo;Casopitant 50 mg;Casopitant 50 mg matching placebo
50 An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666) Completed NCT01934205 Phase 1 GSK2140944 (Single dose);GSK2140944 (Multiple dose)

Search NIH Clinical Center for Posttransplant Acute Limbic Encephalitis

Genetic Tests for Posttransplant Acute Limbic Encephalitis

Anatomical Context for Posttransplant Acute Limbic Encephalitis

MalaCards organs/tissues related to Posttransplant Acute Limbic Encephalitis:

40
Skin, Liver, Breast, Kidney, Bone, Eye, Brain

Publications for Posttransplant Acute Limbic Encephalitis

Articles related to Posttransplant Acute Limbic Encephalitis:

(show top 50) (show all 8352)
# Title Authors PMID Year
1
Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia. 61
32112177 2020
2
Colorimetric determination of cysteamine based on the aggregation of polyvinylpyrrolidone-stabilized silver nanoparticles. 61
32335419 2020
3
Causes of double-negative T-cell lymphocytosis in children and adults. 61
31810993 2020
4
Phosphoproteome analysis of sarcoplasmic and myofibrillar proteins in stress-induced dysfunctional broiler pectoralis major muscle. 61
32169763 2020
5
Colorectal Cancer Screening for the Serrated Pathway. 61
32439082 2020
6
Dual catalytic DNA circuit-induced gold nanoparticle aggregation: An enzyme-free and colorimetric strategy for amplified detection of nucleic acids. 61
32169450 2020
7
Molecular and morphological evidence for sibling species within Anopheles (Anopheles) lindesayi Giles (Diptera: Culicidae) in Bhutan. 61
32283092 2020
8
From Beyond the Pale to the Pale Riders: The Emerging Association of Bacteria with Oral Cancer. 61
32091956 2020
9
Identification of a novel bacterial taxon associated with bovine mastitis showing a close evolutionary relationship with Elizabethkingia sp. 61
32146293 2020
10
A 8- year Bangladeshi girl with disseminated histoplasmosis, presented as chronic liver disease with portal hypertension: a rare case report. 61
32513141 2020
11
Pale (Clear) Cell Acanthoma of the Palate. 61
31230231 2020
12
Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms. 61
31994201 2020
13
The rare case of elevated signet ring cell gastric carcinoma with Helicobacter pylori-naïve mucosa. 61
32495143 2020
14
Mapping the canine vector-borne disease risk in a Mediterranean area. 61
32493470 2020
15
Immunohistochemical Characteristics of Thymomas and Hyperplastic Lesions in Wistar Hannover Rats. 61
32508247 2020
16
A Robust Porous Quinoline Cage by Transformation of a [4+6]-Salicylimine Cage via Povarov-Cyclization. 61
32521080 2020
17
Genome-wide association studies for iris pigmentation and heterochromia patterns in Large White pigs. 61
32232994 2020
18
Melanoma Genomics. 61
32346746 2020
19
Toxic Optic Neuropathy From Quinine Overdose. 61
31842144 2020
20
An enhanced gas sensor based on SiO2@mesoporous MCM-41 core-shell nanocomposites for SO2 visual detection. 61
32501460 2020
21
Characterization of Roseibacterium persicicum sp. nov., and emended description of the genus Roseibacterium. 61
32573683 2020
22
Stab wound of the superficial femoral artery early diagnosed by point-of-care Doppler ultrasound. 61
32542421 2020
23
Autoradiography and inmmunolabeling suggests that lizard blastema contains arginase-positive M2-like macrophages that may support tail regeneration. 61
32512203 2020
24
Temporal dominance of sensations and check-all-that-apply analysis of restructured cooked hams elaborated with different salt content and pork quality meats. 61
32536217 2020
25
Male adnexal tumor of probable Wolffian origin: a new entity in males similar to female adnexal tumor of probable Wolffian origin. 61
32506155 2020
26
Green chemistry based in-situ synthesis of silver nanoparticles for multifunctional finishing of chitosan polysaccharide modified cellulosic textile substrate. 61
31783071 2020
27
Liver colour scoring index, carotenoids and lipid content assessment as a proxy for lumpfish (Cyclopterus lumpus L.) health and welfare condition. 61
32488000 2020
28
Quantitation of copper chlorophylls in green table olives by ultra-high-performance liquid chromatography with inductively coupled plasma isotope dilution mass spectrometry. 61
32252985 2020
29
Sequence analysis and protein interactions of Arabidopsis CIA2 and CIL proteins. 61
32556735 2020
30
Fluorescent redox-dependent labeling of lipid droplets in cultured cells by reduced phenazine methosulfate. 61
32566788 2020
31
Characterization, Phylogenetic Analyses, and Pathogenicity of Enterobacter cloacae on Rice Seedlings in Heilongjiang Province, China. 61
32320370 2020
32
CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris. 61
32525988 2020
33
[Keraunoparalysis after lightning injury with transient ischaemia and paralysis of an extremity]. 61
32515340 2020
34
Solution-Processable Copolymers Based on Triphenylamine and 3,4-Ethylenedioxythiophene: Facile Synthesis and Multielectrochromism. 61
32578302 2020
35
Comparison of activity, expression and S-nitrosylation of glycolytic enzymes between pale, soft and exudative and red, firm and non-exudative pork during post-mortem aging. 61
31978718 2020
36
Differences between auto-fluorescence and tetracycline-fluorescence in medication-related osteonecrosis of the jaw-a preclinical proof of concept study in the mini-pig. 61
32444918 2020
37
[Vasovagal syncope or postural orthostatic tachycardia syndrome in children with neurological symptoms at disease onset: a clinical analysis of 88 cases]. 61
32434646 2020
38
Predictors of visual functional outcome following treatment for cavernous sinus meningioma. 61
32413851 2020
39
Discovery of heterozygous KRT10 alterations in MAUIE patients underlines the importance of regular skin cancer screening in ichthyosis with confetti-patients. 61
32407542 2020
40
Epidemiological and clinical characteristics of severe hand-foot-and-mouth disease (HFMD) among children: a 6-year population-based study. 61
32460823 2020
41
Experimental evidence that matching habitat choice drives local adaptation in a wild population. 61
32429813 2020
42
Radial peripapillary capillary density in superior segmental optic hypoplasia measured with OCT angiography. 61
32448227 2020
43
Narrow-band imaging for scar (NBI-SCAR) classification: from conception to multicenter validation. 61
31494134 2020
44
Synthesis and crystal structures of tetra-meric [2-(4,4-dimethyl-2-oxazolin-2-yl)anilido]sodium and tris-[2-(4,4-dimethyl-2-oxazolin-2-yl)anilido]ytterbium(III). 61
32431936 2020
45
Clinical Implications of Goblet Cells in Dacryoadenosis and Normal Human Lacrimal Glands. 61
32006483 2020
46
Volvariella turcica, a new species from Turkey, and a multigene phylogeny of Volvariella. 61
32330409 2020
47
Cytologic, histologic, microbiologic, and electron microscopic characterization of a canine Prototheca wickerhamii infection. 61
32468599 2020
48
Inflammatory Pseudotumor in the Nasal Cavity and Sinuses: A Case Report and Associated Literature Review. 61
32419496 2020
49
Isolated Ocular Sarcoidosis Mimicking Ring Melanoma. 61
32509763 2020
50
Post-mortem CT with macroscopic and microscopic correlation in a case of sudden death due to systemic sarcoidosis. 61
32474826 2020

Variations for Posttransplant Acute Limbic Encephalitis

Expression for Posttransplant Acute Limbic Encephalitis

Search GEO for disease gene expression data for Posttransplant Acute Limbic Encephalitis.

Pathways for Posttransplant Acute Limbic Encephalitis

GO Terms for Posttransplant Acute Limbic Encephalitis

Sources for Posttransplant Acute Limbic Encephalitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....